These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 22216257)
1. Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis. Solomon JA; Gianforcaro A; Hamadeh MJ PLoS One; 2011; 6(12):e29354. PubMed ID: 22216257 [TBL] [Abstract][Full Text] [Related]
2. Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis. Moghimi E; Solomon JA; Gianforcaro A; Hamadeh MJ PLoS One; 2015; 10(5):e0126355. PubMed ID: 26020962 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females. Gianforcaro A; Solomon JA; Hamadeh MJ PLoS One; 2013; 8(2):e30243. PubMed ID: 23405058 [TBL] [Abstract][Full Text] [Related]
4. Dietary vitamin D3 supplementation at 10× the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study. Gianforcaro A; Hamadeh MJ CNS Neurosci Ther; 2012 Jul; 18(7):547-57. PubMed ID: 22591278 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS). Trojsi F; Siciliano M; Passaniti C; Bisecco A; Russo A; Lavorgna L; Esposito S; Ricciardi D; Monsurrò MR; Tedeschi G; Santangelo G Eur J Clin Nutr; 2020 Jan; 74(1):167-175. PubMed ID: 31197218 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D as a potential therapy in amyotrophic lateral sclerosis. Gianforcaro A; Hamadeh MJ CNS Neurosci Ther; 2014 Feb; 20(2):101-11. PubMed ID: 24428861 [TBL] [Abstract][Full Text] [Related]
7. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320 [TBL] [Abstract][Full Text] [Related]
8. One universal common endpoint in mouse models of amyotrophic lateral sclerosis. Solomon JA; Tarnopolsky MA; Hamadeh MJ PLoS One; 2011; 6(6):e20582. PubMed ID: 21687686 [TBL] [Abstract][Full Text] [Related]
9. Epothilone D accelerates disease progression in the SOD1 Clark JA; Blizzard CA; Breslin MC; Yeaman EJ; Lee KM; Chuckowree JA; Dickson TC Neuropathol Appl Neurobiol; 2018 Oct; 44(6):590-605. PubMed ID: 29380402 [TBL] [Abstract][Full Text] [Related]
10. C-Boutons and Their Influence on Amyotrophic Lateral Sclerosis Disease Progression. Wells TL; Myles JR; Akay T J Neurosci; 2021 Sep; 41(38):8088-8101. PubMed ID: 34380764 [TBL] [Abstract][Full Text] [Related]
11. Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 ( Wang S; Ichinomiya T; Savchenko P; Wang D; Sawada A; Li X; Duong T; Li W; Bonds JA; Kim EJ; Miyanohara A; Roth DM; Patel HH; Patel PM; Tadokoro T; Marsala M; Head BP Theranostics; 2022; 12(12):5389-5403. PubMed ID: 35910808 [TBL] [Abstract][Full Text] [Related]
12. Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice. Hamadeh MJ; Tarnopolsky MA Muscle Nerve; 2006 Dec; 34(6):709-19. PubMed ID: 16941656 [TBL] [Abstract][Full Text] [Related]
13. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1 Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766 [TBL] [Abstract][Full Text] [Related]
14. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis. Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030 [TBL] [Abstract][Full Text] [Related]
15. [Early electroacupuncture intervention delays progression of disease in mice with amyotrophic lateral sclerosis by down-regulating TLR4/NF-κB signaling]. Wang SL; Sun YZ; Yu TY; Zhao GR; Sun Y Zhen Ci Yan Jiu; 2023 Mar; 48(3):287-93. PubMed ID: 36951082 [TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model. Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002 [TBL] [Abstract][Full Text] [Related]
17. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224 [TBL] [Abstract][Full Text] [Related]
18. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1 Winter AN; Ross EK; Wilkins HM; Stankiewicz TR; Wallace T; Miller K; Linseman DA Nutr Neurosci; 2018 Jul; 21(6):414-426. PubMed ID: 28276271 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis. Karam C; Barrett MJ; Imperato T; MacGowan DJ; Scelsa S J Clin Neurosci; 2013 Nov; 20(11):1550-3. PubMed ID: 23815870 [TBL] [Abstract][Full Text] [Related]
20. Protocatechuic Acid Extends Survival, Improves Motor Function, Diminishes Gliosis, and Sustains Neuromuscular Junctions in the hSOD1 Koza LA; Winter AN; Holsopple J; Baybayon-Grandgeorge AN; Pena C; Olson JR; Mazzarino RC; Patterson D; Linseman DA Nutrients; 2020 Jun; 12(6):. PubMed ID: 32570926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]